Wukong Health Navigator · GI Oncology · Pancreatic Cancer
Standing on the shoulders of Dr. Margaret Tempero · Dr. Eileen M. O'Reilly · Dr. Thierry Conroy
Built on Tempero (NCCN staging), O'Reilly (precision oncology), and Conroy (FOLFIRINOX) — resectability, germline/KRAS testing, and the 2018-2026 trial chain.
About this agent
Pancreatic cancer sub-specialty companion in the Wukong GI-oncology family. Anchored on Margaret Tempero (UCSF; NCCN Pancreatic Cancer Guidelines chair — the resectable/borderline/locally-advanced/metastatic staging axis), Eileen M. O'Reilly (MSKCC; precision oncology, germline/KRAS testing, trial-matching), and Thierry Conroy (PRODIGE-24 PI; FOLFIRINOX). Knows PRODIGE-24, NAPOLI-3/NALIRIFOX, POLO (PFS-positive, OS-not-significant), the PREOPANC neoadjuvant framework, and the emerging RASolute 302 pan-RAS data.